Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06009289 · ClinicalTrials.gov registry record · Phase 4
Light and Sleep Fragmentation
A Phase 4 study, sponsored by Stanford University.
- Not yet
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT06009289: Clinical Trial Phase 4 study, sponsored by Stanford University.
NCT06009289 is a Phase 4 study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06009289, a Phase 4 study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
This trial will examine scheduled exposure to bright light in the morning and afternoon as a countermeasure to sleep fragmentation in older individuals with mild cognitive impairment.
Interventions
- BEHAVIORAL Light therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-05-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06009289
The ClinicalTrials.gov registry entry for NCT06009289 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Light therapy is the first listed.
NCT06009289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06009289 about?
NCT06009289 is a clinical study titled "Light and Sleep Fragmentation". This trial will examine scheduled exposure to bright light in the morning and afternoon as a countermeasure to sleep fragmentation in older individuals with mild cognitive impairment.
What is the current status of trial NCT06009289?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2026-06-01. Estimated completion is 2028-05-30.
What interventions are being tested in trial NCT06009289?
The interventions under investigation include: Light therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06009289?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.